Synthon Pharmaceuticals, Inc.

Filing 58

ORDER granting 57 Motion to Substitute Party. Mylan Pharmaceuticals Inc. added. Synthon Pharmaceuticals, Inc. terminated. Signed by Chief Judge James C. Dever III on 8/1/2017. (Briggeman, N.)

UNITED STATES DISTRICT COURT
FOR THE EASTERN DISTRICT OF NORTH CAROLINA
WESTERN DIVISION

SYNTHON PHARMACEUTICALS, INC. [to be
substituted out]; MYLAN PHARMACEUTICALS
INC. [to be substituted in]

CIVIL ACTION NO:
5:10-cv-00150-D

Plaintiffs,

v.
ELI LILLY and COMPANY and ICOS
CORPORATION,
Defendants.
CIVIL ACTION NO.
ELI LILLY AND COMPANY and, ICOS
CORPORATION,

5: 10-cv -0402-D

Plaintiffs,

v.
SYNTHON PHARMACEUTICALS INC. [to be
substituted out]; MYLAN PHARMACEU'IJCALS
INC. [to be substituted in]
Defendants.

ORDER SUBSTITUTING MYLAN PHARMACEUTICALS INC.
FOR SYNTHON PHARMACEUTICALS, INC.

THIS MATTER is before the Court on the Stipulated Motion for Consent Order
Substituting Mylan Pharmaceuticals Inc. for Synthon Pharmaceuticals, Inc. filed by all parties. It
appears to the Court that good cause exists to grant the Motion.
WHEREFORE, the Stipulated Motion for Consent Order Substituting Mylan
Pharmaceuticals Inc. for Synthon Pharmaceuticals, Inc. is hereby GRANTED.

IT

IS

HEREBY

ORDERED,

ADJUDGED,

AND

DECREED

that

Mylan

Pharmaceuticals Inc. is substituted for Synthon Pharmaceuticals, Inc. as Plaintiff in Civil Action
No.

5:10-cv-00150-D

and

Mylan

Pharmaceuticals

Inc.

is

substituted

for

Synthon

Pharmaceuticals, Inc. as Defendant in 5:10-cv-0402-D.
SO ORDERED. This

A~'iusf

_t_day of JotttY2017.

Chief United States District Judge